Sarcopenia - Endocrinological and Neurological Aspects

Area of Science:

• Geriatric Medicine
• Endocrinology
• Neuroscience
• Muscle Physiology

Background:

• Sarcopenia in the elderly often stems from complex endocrine and nervous system alterations.
• Multimorbidity in geriatric patients complicates the study of sarcopenia's distinct pathogenic pathways.
• Specific conditions like diabetes and motor neuron diseases exhibit unique sarcopenic phenotypes.

Purpose of the Study:

• To utilize well-defined disease models to investigate isolated endocrinological and neurodegenerative causes of sarcopenia.
• To develop a mechanism-oriented classification algorithm for sarcopenia in geriatric patients.
• To facilitate the development of targeted therapies for sarcopenia.

Main Methods:

• Review of diseases with known etiopathogenesis of muscle impairment.
• Analysis of patient cohorts with conditions affecting muscle properties (e.g., diabetes, ALS).
• Identification of distinct sarcopenic phenotypes in younger patients with known molecular disease mechanisms.

Main Results:

• Diseases with known molecular mechanisms serve as valuable models for studying sarcopenia.
• Distinct endocrinological and neurodegenerative pathways contribute to sarcopenia.
• Understanding these pathways is crucial for developing effective classification and treatment strategies.

Conclusions:

• Studying specific diseases provides insights into sarcopenia's underlying mechanisms.
• A classification algorithm based on pathogenic pathways can enable mechanism-oriented therapies for geriatric sarcopenia.
• This approach holds promise for improving treatment outcomes in elderly patients with sarcopenia.